Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 162 Carcinoma, Non-Small-Cell Lung 109 Lung Neoplasms 54 Hodgkin Disease 22 Neoplasm Metastasis 16 Recurrence 15 Lymphoma 15 Neoplasms 14 Triple Negative Breast Neoplasms 13 Prostatic Neoplasms 10 Adenocarcinoma of Lung 10 Sarcoma 9 Rhabdomyosarcoma 9 Uterine Cervical Neoplasms 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Large B-Cell, Diffuse 6 Ovarian Neoplasms 5 Mesothelioma, Malignant 5 Breast Neoplasms, Male 5 Small Cell Lung Carcinoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 NSCLC 4 Multiple Myeloma 4 Brain Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Mesothelioma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

Dexamethasone 21 Calcium Dobesilate 10 Melphalan 9 Bortezomib 8 Cyclophosphamide 7 Lenalidomide 6 pomalidomide 4 miridesap 3 daratumumab 3 venetoclax 2 ixazomib 2 belantamab mafodotin 2 Thalidomide 2 Doxycycline 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 selinexor 1 pegfilgrastim 1 isatuximab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carfilzomib 1 birtamimab 1 auricularum 1 Vinorelbine 1 Technetium Tc 99m Pyrophosphate 1 Technetium 1 Tacrolimus 1 Surveys and Questionnaires 1 Pharmaceutical Preparations 1 Lisaftoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Amyloidosis × Vinorelbine × Clear all

NCT02791373 2018-04-03

ViGeM

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡